Your best medicine news resource
Jan 3rd 2009Drug InformationEar, Nose and Throat
A simple 13-point symptom score can help in tracking improvement in infants and toddlers with middle ear infection, or acute otitis media (AOM), reports a study in the January issue of The Pediatric Infectious Disease Journal.
More: continued here
Jan 3rd 2009Drug InformationEar, Nose and Throat
Neuromonics, Inc. recently announced that it has been designated to receive $1 million in funding through the Department of Defense to study the treatment of tinnitus among military servicemembers. The Neuromonics Tinnitus Treatment is a clinically proven treatment, offering long-term relief by comprehensively targeting the neurological root causes of tinnitus.
More: continued here
Jan 3rd 2009Drug InformationEar, Nose and Throat
Ipsen (Paris:IPN) today announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter for its Biologics License Application (BLA) for its Botulinum toxin Type A, DysportŪ. The application, submitted by the Group in late 2007, seeks approval to market DysportŪ for the treatment of cervical dystonia. The Group is now actively preparing to launch the product, once approved by the FDA, and as soon as reimbursement coverage is adequate.
More: continued here
Your best medicine news resource
